Last update on: 04/09/2009
- Neuroblastomas are the 2nd most common cause of death in small children.
- An urgent need of new methods for diagnosis exists.
- As even this common tumour is much too uncommon in individual countries in order to recruit a sufficient amount of patients for clinical studies, research is being conducted here within an international network of a multicentre European study. The resource-intensive project is funded primarily by the EU under the direction of the St. Anna Children’s Cancer Research Institute: www.siopen-r-net.org
For over 20 years, Univ.-Doz. Dr. Peter Ambros has worked in tumour research.His goal is to characterise neuroblastomas in greater detail.
The molecular tumour profile supports doctors in selecting the proper treatment: For patients with comparatively 'tame' neuroblastomas, the burden of radiation and chemotherapy following the operative removal of the tumour is avoided. St. Anna is one of the first institutions in the world that has made this procedure possible - success in healing with surgical measures without chemotherapy.